Українська English

ISSN 2522-9028 (Print)
ISSN 2522-9036 (Online)
DOI: https://doi.org/10.15407/fz

Fiziologichnyi Zhurnal

is a scientific journal issued by the

Bogomoletz Institute of Physiology
National Academy of Sciences of Ukraine

Editor-in-chief: V.F. Sagach

The journal was founded in 1955 as
1955 – 1977 "Fiziolohichnyi zhurnal" (ISSN 0015 – 3311)
1978 – 1993 "Fiziologicheskii zhurnal" (ISSN 0201 – 8489)
1994 – 2016 "Fiziolohichnyi zhurnal" (ISSN 0201 – 8489)
2017 – "Fiziolohichnyi zhurnal" (ISSN 2522-9028)

Fiziol. Zh. 2013; 59(2): 85-91

Pathogenetic substantiation of using peptidases in the treatment of patients with generalized periodontitis

Serheieva IIe

    National Medical University, Kyiv, Ukraine
DOI: https://doi.org/10.15407/fz59.02.085


Abstract

76 patients of whom 52 patients with GP-II degree exacerbative and 24 somatically healthy people aged 20-50 years were studied. Based on these immunological examination serapeptydase was assigned per os, as a complementary product to the basic therapy. Any concentration of secretory leukocyte protease inhibitor (SLPI) indicates the dominant hyperergic inflammation in periodontal tissues, accompanied by increased proteolysis. Profitable accumulation in the serum of patients with GP inhibitors proteinase to 53%, IL-1beta - to 26.3%, IL-2 - to 19.5%, IL-8 - to 42.8% FNPalpha - up to 48.3%, and reduction of IFNalpha to 78.1% indicates changes of complex "protease-antiproteases" immunocompetent cells and activation of inflammatory processes at the local and systemic levels.

Keywords: generalized periodontitis, cytokines, SLPI (secretoryleukocyte protease inhibitor), TNF-б, IFN-б, phagocyticindex, phagocytic number.

Full text: (PDF, in Ukrainian)

References

  1. Veremeenko K.N. Terapevticheskoe ispol'zovanie fermentov i ih ingibitorov v meditsinskoi praktike . Fermenti v narodnom hozyaistve i meditsine. K.,1971. Vip.6. P.221-234.
    2.  
  2. Veremeenko K.N., Homenko L.A., Kizim A.I. Fermenti slyuni i ih issledovaniya . Lab. delo. 1976. N 7. P.393-398. PubMed
    3.  
  3. Grigor'yan A.S., Grudyanov A.I. Klyuchevie zven'ya patogeneza zabolevanii parodonta v svete dannih tsitomorfometricheskogo metoda issledovaniya . Stomatologiya. 2001. N 1. P.5-8.
    4.  
  4. Kosenko K.M., Tereshina T.P. Profilakticheskaya gigiena polosti rta. Odessa: Izd-vo KP OGT, 2003. 296 p.
    5.  
  5. Mashchenko I.S., Serbinenko E.V. Opredelenie bakteritsidnogo i antioksidantnogo potentsiala neitrofil'nih granulotsitov u bol'nih generalizovannim parodontitom . Sovr. stomatologiya. 2003. N 1. P.51-53.
    6.  
  6. Pat. 52179 MPK G01N 33/48. Sposib otsinki perebigu generalizovanogo parodontitu. Sergeieva I.Ie. Opubl. 10.08.10. Byul. N 15.
    7.  
  7. Pat. 57223 MPK A61K 6/00. Sposib likuvannya hvorih na generalizovanii parodontit hronichnogo ta zagostrenogo perebigu. Sergeieva I.Ie. Opubl. 10.02.11. Byul. N 3.
    8.  
  8. Sisovets A.S., Levitskii A.P. Ingibitori proteoliticheskih fermentov v meditsine. K.:Zdorov'ya,1979. 77 p.
    9.  
  9. Chumakova Yu.G. Rol' leikotsitov v patogeneze genera-lizovannogo parodontita: osobennosti pri razlichnih form zabolevaniya . Visnik stomatologii. 2007. N 1. P.17-30.
    10.  
  10. Cox S.W., Eley B.M., Kiili M., Asikainen A., Tervahartiala T., Sorsa T. Collagen degradation by interleukin-1-betastimulated gingival fibroblast is accompanied by release and activation of multiple matrix metalloproteinases and cysteine proteinases . Oral. Diseases. 2006. N 12. P. 34-40. CrossRef PubMed
    11.  
  11. Craandijik J., van Krugten M.V., Verweij C.L., van der Velden U., Loos B.G. Tumor necrosis factor-? gene polymorphisms in relation to periodontitis . J. Clin.Periodontol. 2002. N 29. P. 328-334.
    12.  
  12. Delima A.J., Karataz S., Amar S., Graves D.T. Inflammation and tissue loss caused by periodontal pathogens in reduced by interleukin-1 antagonists . J. Infect. Dis. 2002. N 186. P. 511-516. CrossRef PubMed
    13.  
  13. Engebreston S.P., Gibric J.T., Singer R., Lamster I.B. GCF IL-1? profiles in periodontal disease . J. Clin. Periodontol. 1991. N 18. P. 548-554.
    14.  
  14. Han R., Smith T.J. Induction by IL-1? of tissue inhibitor of metalloproteinase-9 by human skin . Surgery. 2005. N 138. P. 932-939. CrossRef PubMed PubMedCentral
    15.  
  15. Hiemestra P.S., Fernie-King B.A., McMichael J. Antimicrobial peptides: mediators of innate immunity as templates for the development of novel anti-infective and immune therapeutics . Curr. Pharm. Des. 2004. N 10. P. 2891-2905. CrossRef  
  16. Kinae D.F., Hart T.C. Gene and gene polymorphisms associated with periodontal disease . Crit. Rev. Oral. Biol. Med. 2003. N 14. P. 430-449. CrossRef  
  17. Mihaila A., Tremblay G.M. Human alveolar macrophages express elafin and secretory leukocyte protease inhibitor . Z. Naturforsch. 2001. N 56. P. 291-297. CrossRef  
  18. Odaka C., Mizuochi T., Yang J. Murine macrophages produce secretory leukocyte protease inhibitor during clearance of apoptotic cells: implications for resolution of the inflammatory respose . J. Immunol. 2003. N 171. P. 1507-1514. CrossRef PubMed
    19.  
  19. Tralau T., Meyer-Hoffert U., Schroder J.M., Wiedow O. Human leukocyte elastase and cathepsin G are specific inhibitors of C5a-dependent neutrophil enzyme release and chemotaxis. Exp. Dermatol. 2004. N 13. P. 316-325. CrossRef PubMed
    20.  

© National Academy of Sciences of Ukraine, Bogomoletz Institute of Physiology, 2014-2024.